📰 Cell Technologies News
Page 10 - Cell Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Technologies. Real-time updates on events, politics, business and more.
February 16, 2023
IMUGARD to Help Strained U.S. Platelet Supply Meet Growing Need LAKEWOOD, Colo., Feb. 17, 2023 /PRNewswire/ -- Today, Terumo Blood and Cell Technologies announces U.S. Food and Drug Administration (FDA) clearance and official launch of its IMUGARD® WB Platelet Pooling Set, which supports extended shelf life of whole blood-derived platelets from five days to seven days.[1] IMUGARD is the...
February 9, 2023
German-headquartered EKPO Fuel Cell Technologies has secured a contract from a European car manufacturer for fuel cell stacks to be fitted to a future series production vehicle.
February 2, 2023
EQS-News: ElringKlinger AG / Key word(s): Incoming Orders EKPO to develop and supply fuel cell stacks for a European OEM 02.02...
January 30, 2023
/PRNewswire/ -- Scientists at Artificial Cell Technologies (ACT) have developed a fully synthetic microparticle vaccine for Respiratory Syncytial Virus (RSV)...
January 17, 2023
French auto supplier Plastic Omnium and Shanghai-based Shenergy Group subsidiary Rein will establish a 50/50 joint venture based in Shanghai to manufacture and market high-pressure hydrogen storage systems for the commercial vehicle market in China.
December 28, 2022
Growth in Colorado’s life sciences industry is being fueled by its success in raising funds, access to an educated workforce and research coming out of the state’s universities.
December 9, 2022
/PRNewswire/ -- The "Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
December 2, 2022
The Automotive Fuel Tank market is expected to hit US$ 22.0 billion by 2030, recording a CAGR of 5.1% during the forecast period.
November 10, 2022
Conference Call Thursday November 10, 2022 at 4:30 p.m. ET...
October 20, 2022
SONOMA, Calif. (PRWEB) October 20, 2022 -- Pulthera, LLC has received notice from the U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)